Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-3.27	18.75	19.38
Graham Fair Price	45.80	13.73	9.42
PEG	341.97	4.67	-1.06
Price/Book	-40.62	1.54	2.59
Price/Cash Flow	-90.94	13.17	-145.34
Prices/Earnings	9.82	31.16	28.37
Price/Sales	-43.58	2.20	3.90
Price/FCF	-90.94	13.17	-145.34
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-1.94	0.25	0.26
Operating Margin	-31.11	0.04	0.06
ROA	-49.31	< 0.005	< 0.005
ROE	0.02	0.01	-45.93
ROIC	0.02	< 0.005	-46.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	-0.01	-44.72
Dividends QOQ	-1.00	0.60	-39.57
EBIT QOQ	-0.11	-0.28	-148.20
EPS QOQ	-0.27	0.07	-75.15
FCF QOQ	-1.42	7.50	428.06
Revenue QOQ	-0.03	0.04	28.99
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	78.18	67.04	-14.24
Days Sales Outstanding (DSO)	67.34	54.14	-19.59
Inventory Turnover	1.15	1.34	16.61
Debt/Capitalization	0.37	0.29	-23.09
Quick Ratio	0.91	0.90	-1.90
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	13.13	26.04	98.28
Cash	4.66	10.71	129.99
Capex	-0.76	-0.06	92.42
Free Cash Flow	-0.23	3.04	1199.30
Revenue	8.72	18.20	108.70
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.37	1.40	1.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.97	0.74	-23.16
Naive Interpretation	Member

06 - Financial Health · Weak

Rating